Perrigo Counters Meth Act Fallout With New Products, Reformulations
This article was originally published in The Tan Sheet
Executive Summary
New product launches, particularly in the smoking cessation category, helped contribute to a 7% rise in sales to $341.9 mil. for Perrigo's first quarter 2007, according to company President and CEO Joseph Papa
You may also be interested in...
Perrigo Foresees 2008 Omeprazole Launch; New Products Offset Sales Woes
Perrigo expects to be able to launch the first store-brand equivalent to Prilosec OTC in November 2008, at the expiration of a 30-month stay
Acetaminophen Recall Costs Perrigo $2.9 Mil.
Perrigo will take a $2.9 mil. earnings hit for recalling roughly 11 mil. bottles of acetaminophen after it found small metal fragments in some of the 500 mg caplets, the private labeler said
New Products In Brief
Perrigo generic Nicorette approval: The Allegan, Mich.-based generics manufacturer has received FDA approval to market store-brand versions of GlaxoSmithKline's Nicorette Fresh Mint (coated nicotine polacrilex gum 2 mg and 4 mg) smoking cessation gum, the firm announces June 14. Retail sales for GSK's Fresh Mint gum were approximately $100 mil. for the past 12 months. Perrigo currently produces generic versions of GSK's uncoated NRT gum products as well as nicotine polacrilex lozenges equivalent to GSK's Commit product. "We are pleased with this important addition to our store brand nicotine replacement therapy product offerings, even though some sales may come at the expense of our uncoated gum products," Executive VP and General Manager - Perrigo Consumer Healthcare John Hendrickson states. The product will begin shipping to food, drug, mass market, dollar store and club store retailers in the fourth quarter and will cost approximately 25% to 40% less than the branded, the firm says...